<DOC>
	<DOCNO>NCT00135564</DOCNO>
	<brief_summary>The purpose booster vaccination study evaluate persistence immune memory induce three-dose primary vaccination course GSK Biologicals ' MenC-TT ( Neisseria meningitidis group C polysaccharide-tetanus toxoid ) GSK Biologicals ' Hib-MenC-TT ( Haemophilus influenzae type b-MenC-TT ) Meningitec™ vaccines healthy toddler age 12-15 month give 1/5th dose Mencevax™ ACWY .</brief_summary>
	<brief_title>Study Evaluate GlaxoSmithKline ( GSK ) Biologicals ' MenC-TT Hib-MenC-TT Meningitec™ Healthy Toddlers</brief_title>
	<detailed_description>The study extension primary vaccination study 711202/001 ( MenC-TT-001 ) . It comprise 5 group : 4 parallel group toddler vaccinate study 711202/001 ( group vaccinate Meningitec™ control group 1 ) 1 group naive subject ( previous vaccination MenC disease , control group 2 ) . All subject receive 1/5th dose Mencevax™ ACWY concomitant dose Infanrix hexa® . 2 blood sample : prior 1 month vaccination .</detailed_description>
	<mesh_term>Meningococcal Infections</mesh_term>
	<criteria>Healthy toddler ( 1215 ) least 1 dose 3dose vaccination course MenC HibMenC vaccine study 711202/001 , OR without previous vaccination MenC disease complete primary vaccination accord German Standing Committee Immunization ( STIKO ) recommendation least 6 month enrolment Previous/intercurrent booster vaccination OR history OR exposure diphtheria , pertussis , tetanus , polio , hepatitis B , Hib and/or meningococcal disease . Planned administration/administration vaccine within 30 precede study vaccination study end exception Infanrix hexa® . Any confirm suspected immunosuppressive immunodeficient condition , include human immunodeficiency virus ( HIV ) infection . A family history congenital hereditary immunodeficiency . History neurologic disorder seizure , allergic disease/reactions likely exacerbate component vaccine</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>15 Months</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Haemophilus Influenzae type b/Meningococcal ( vaccine )</keyword>
	<keyword>Prophylaxis meningococcal serogroup C disease , Hib disease</keyword>
</DOC>